Pharmaceutical Technology's In the Lab eNewsletter
Recent drug recalls in the United States from nitrosamine contamination prompt the need for more sensitive impurity testing methods and a re-evaluation of acceptable lower limit levels.
Andrew James
Advertisement
Articles by Andrew James
Advertisement
Latest Updated Articles
- Testing for Nitrosamines in Pharmaceutical Drugs
June 3rd 2020
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma Fundamentals: Hold Times in Biopharmaceuticals
2
FDA Updates Master Protocol: What Developers Need to Know
3
FDA Approves Pfizer’s Breast Cancer Treatment
4
Merck KGaA Launches Saturnus Bio; Announces Awards
5